Liquid biopsies and minimal residual disease in myeloid malignancies

Liquid biopsies and minimal residual disease in myeloid malignancies

Minimal residual disease (MRD) assessment through blood component sampling by liquid biopsies (LBs) is increasingly being investigated in myeloid malignancies. Blood components then undergo molecular analysis by flow cytometry or sequencing techniques and can be used as a powerful tool for prognosti...

Full description

Bibliographic Details
Main Authors: Sabine Allam, Kristina Nasr, Farhan Khalid, Zunairah Shah, Mahammed Ziauddin Khan Suheb, Sana Mulla, Sindhu Vikash, Maroun Bou Zerdan, Faiz Anwer, Chakra P. Chaulagain
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Oncology
Subjects:
liquid biopsies
minimal residual disease (MRD)
acute myeloid leukemia
acute myeloid leukemia (AML)
myelodysplastic syndromes (MDS)
myeloid malignancies
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1164017/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1164017/full

Similar Items